Third, DM is an uncommon disease, the small sample size limited statistical analyses, we still identified significant differences in the clinical characteristics and 1-year mortality rates of patients with DM with anti-Jo-1 and anti-MDA5 antibodies. Here, IFIH1 is linked to dermatomyositis.